These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7007855)

  • 1. A review of time-dose effects in radiation therapy.
    Peschel RE; Fischer JJ
    Med Phys; 1980; 7(6):601-8. PubMed ID: 7007855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy: the radiobiological dose-per-fraction effect.
    Song W; Battista J; Van Dyk J
    Med Phys; 2004 Nov; 31(11):3034-45. PubMed ID: 15587657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delay differential equations and the dose-time dependence of early radiotherapy reactions.
    Fenwick JD
    Med Phys; 2006 Sep; 33(9):3526-40. PubMed ID: 17022249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiobiological philosophy of current U.S. neutron trials.
    Withers HR
    Strahlenther Onkol; 1989 Apr; 165(4):294-7. PubMed ID: 2652356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
    Marcu LG
    Cancer Treat Rev; 2010 Dec; 36(8):606-14. PubMed ID: 20494524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A feasibility study: Selection of a personalized radiotherapy fractionation schedule using spatiotemporal optimization.
    Kim M; Stewart RD; Phillips MH
    Med Phys; 2015 Nov; 42(11):6671-8. PubMed ID: 26520757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation biology.
    Hall EJ
    Cancer; 1985 May; 55(9 Suppl):2051-7. PubMed ID: 3919919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first James Kirk memorial lecture. What next in fractionated radiotherapy?
    Fowler JF
    Br J Cancer Suppl; 1984; 6():285-300. PubMed ID: 6365141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and management of radiation myelopathy.
    Ang KK; Stephens LC
    Oncology (Williston Park); 1994 Nov; 8(11):71-6; discussion 78, 81-2. PubMed ID: 7826840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy.
    Jones B; Dale RG
    Br J Radiol; 2005 Oct; 78(934):939-44. PubMed ID: 16177018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New understanding from Cf brachytherapy trials and considerations for neutron therapy of bulky gyn carcinoma for future.
    Maruyama Y; Mesina J; Yudelev M; Wierzbicki J; Deppe G; Porter AT
    Strahlenther Onkol; 1994 May; 170(5):253-63. PubMed ID: 8197547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further radiobiologic modeling of palliative radiotherapy: use of virtual trials.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):221-9. PubMed ID: 17707276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rational dose fractionation schedule 1. Each fractional dose].
    Masuda K; Matsuura K; Miyoshi M; Uehara T
    Gan No Rinsho; 1985 Sep; 31(12):1520-4. PubMed ID: 4079040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Unconventional fractionation schedules--radiobiological basis and clinical possibilities].
    Herrmann T; Voigtmann L
    Radiobiol Radiother (Berl); 1986; 27(1):7-16. PubMed ID: 3704132
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in translational research provide a rationale for clinical re-evaluation of high-dose radiotherapy for glioblastoma.
    Nieder C; Mehta MP
    Med Hypotheses; 2011 Mar; 76(3):410-3. PubMed ID: 21112157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of local control due to tumor displacement as a function of margin size, dose-response slope, and number of fractions.
    Selvaraj J; Uzan J; Baker C; Nahum A
    Med Phys; 2013 Apr; 40(4):041715. PubMed ID: 23556885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation of the optimum dose per fraction from the linear quadratic model.
    Jones B; Tan LT; Dale RG
    Br J Radiol; 1995 Aug; 68(812):894-902. PubMed ID: 7551788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
    Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
    Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.